Orthofeet, a manufacturer of biomechanically designed footwear, today announced two additions to their executive team. Mike DiSotto is joining as VP, manufacturing, and Dennis Janisse, C.Ped., is director of scientific affairs.
“Mike and Dennis bring tremendous expertise and insight to the company at an important stage of our growth,” said Mark Koide, CEO, Orthofeet. “These hires reflect our priorities in expanding our manufacturing and quality capabilities, and strengthening our company's expertise in developing and communicating about outstanding foot care products for people with diabetes and mobility concerns.”
A veteran of the shoe industry, DiSotto has extensive experience in supervising the full-spectrum of the manufacturing process, including procurement, purchasing, manufacturing, and commercialization. At Orthofeet, he will manage all manufacturing responsibilities including leadership of China facilities. He was most recently VP operations at Via Prive Active Wear and director of material development/sourcing/management at the San Antonio Shoe Company.
Janisse, one of the most prominent thought-leaders in the pedorthic industry, has lectured and published extensively on foot care for adults with diabetes. He is Clinical Assistant Professor, Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin. At Orthofeet, he will manage all content creation for health providers including certification courses, educational lectures and workshops. He will also oversee the development of consumer education materials. Mr. Janisse was most recently Director of Pedorthic Education at P.W. Minor & Sons, Inc.
A recent study from the Centers for Disease Control and Prevention (CDC) showed that preventative foot care and therapeutic footwear are key factors behind the 65 percent reduction in diabetes-related amputations over the past decade.
The hires are the latest in a series of management appointments at Orthofeet since Koide joined as CEO in summer of 2011.
